Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002378

Chief Business Development Off sold 6,771 shares at an average $57.39 ($388,583)

  • Chief Business Development Off acquired 6,771 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +2,604 $6.55 $17,056 2,604 D
2021-01-04 Exercise or conversion : show line 2 in the form +2,604 $6.55 $17,056 5,208 D
2021-01-04 Exercise or conversion : show line 3 in the form +1,563 $7.27 $11,363 6,771 D
2021-01-04 Sale : show line 4 in the form −2,209 $56.12 $123,969 4,562 D
2021-01-04 Sale : show line 5 in the form −3,800 $57.82 $219,716 762 D
2021-01-04 Sale : show line 6 in the form −495 $58.63 $29,022 267 D
2021-01-04 Sale : show line 7 in the form −267 $59.46 $15,876 0 D
Open-market sales · 6,771 sh · avg $57.39 · $388,583

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-01-04 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −2,604 26,042 D
2021-01-04 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −2,604 54,688 D
2021-01-04 Exercise or conversion : show line 10 in the form Common Stock (Right to Buy) −1,563 37,500 D
Loading xslF345X03/doc4.xml…